Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Famotidine
Cat. No.:
OB0225LY-0119
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Famotidine is an H2 receptor antagonist with antacid activity.
Synonym:
MK-208; 76824-35-6; Amfamox; Famodil; Pepdine; Pepdul; Gastropen; Pepcidine; Famosan; Famoxal; Fluxid
CAS No.:
76824-35-6
Compound CID:
5702160
Formula:
C8H15N7O2S3
Formula Weight:
337.45
Specification
Relative Density:
1.5111 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Famotidine can be used to study the relief of gastric ulcers, gastroesophageal reflux disease (GERD) and other related gastrointestinal disorders.
Library Information
Targets:
Histamine receptor family
Receptors:
H2 receptor
Pathways:
Immunology/Inflammation; GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
e2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 148.17 mM
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
